Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
PT Siloam International Hospitals Tbk's 10-Year RORE % for the quarter that ended in Mar. 2026 was 0.00%.
FRA:2LS's 10-Year RORE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 6.21 * Ranked among companies with meaningful 10-Year RORE % only.
PT Siloam International Hospitals Tbk (FRA:2LS) 10-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
PT Siloam International Hospitals Tbk 10-Year RORE % Related Terms
PT Siloam International Hospitals Tbk 10-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk 10-Year RORE % Chart
FRA:2LS vs HCA, THC, DVA: 10-Year RORE % Comparison
For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Siloam International Hospitals Tbk 10-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where PT Siloam International Hospitals Tbk's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 10-year before.
PT Siloam International Hospitals Tbk (FRA:2LS) has a 10-Year RORE % of 0.00 as of Mar. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on PT Siloam International Hospitals Tbk and its competitors. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #55 out of 321 companies in the Healthcare Providers & Services industry, placing it in the top 17.1%.
Is PT Siloam International Hospitals Tbk's 10-Year RORE % too high?
PT Siloam International Hospitals Tbk's current 10-Year RORE % is 0.00. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #55 out of 321 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's 10-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #55 out of 321 companies for 10-Year RORE %. This places PT Siloam International Hospitals Tbk in the top 17% of its industry — outperforming the majority of peers. The industry median 10-Year RORE % is 6.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Healthcare Providers & Services company?
The median 10-Year RORE % among Healthcare Providers & Services companies is 6.21, based on 321 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on PT Siloam International Hospitals Tbk and its competitors. For the Healthcare Providers & Services industry, the median 10-Year RORE % is 6.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current 10-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.13, compared to a current price of €0.10 — trading 23.1% below its estimated fair value. The current 10-Year RORE % is 0.00. PT Siloam International Hospitals Tbk's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current 10-Year RORE % is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.10 is trading 23.1% below its estimated GF Value™ of €0.13.
GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.
Key valuation signals for FRA:2LS:
10-Year RORE %: 0.00
GF Value™: €0.13 vs. price of €0.10 (23.1% below fair value)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
68GF Score
Get the complete analysis for FRA:2LS
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
